Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lichan Mao"'
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/fbf3bbaca025455a9cbd30cccbec90cd
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundNonalcoholic fatty liver disease (NAFLD), also known as metabolic associated fatty liver disease (MAFLD), is a common liver condition characterized by excessive fat accumulation in the liver which is not caused by alcohol. The main causes o
Externí odkaz:
https://doaj.org/article/9befe90765064467835ee73af4d372f9
Autor:
Wenhao Xu, Jinli Yang, Xiangyang Gu, Wenjing Su, Faxiang Pu, Zhangfu Xie, Kongliang Jin, Weike Su, Lichan Mao
Publikováno v:
Drug Delivery, Vol 29, Iss 1, Pp 351-363 (2022)
Ibuprofen (IBU) was a widely used NSAID (a type of nonsteroidal anti-inflammatory drug) worldwide, and many drug deliveries had been reported to enhance bioavailability. However, higher bioavailability would increase the danger of renal injury caused
Externí odkaz:
https://doaj.org/article/9581997ece23475981ae26a906c1593f
Publikováno v:
Analytical Cellular Pathology, Vol 2022 (2022)
Tetrandrine (Tet), a compound found in a traditional Chinese medicine, presents the protective effect for kidney function. Our study is aimed at clarifying the efficacy and underlying mechanism of Tet on podocyte injury. In this study, podocyte injur
Externí odkaz:
https://doaj.org/article/8d06c6174c21480bb1592ccc6b087d96
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM. 2022
Background. Fangji Huangqi decoction (FHD) is a traditional Chinese medicine formula that has the potential efficacy for nephrotic syndrome (NS) treatment. This study aims to explore the effects and underlying mechanisms of FHD against NS via network
Publikováno v:
Frontiers in Medicine; 2024, p1-1, 1p
Publikováno v:
Frontiers in Medicine; 2024, p1-19, 19p
Autor:
Mao, Lichan1 (AUTHOR), Ding, Yin1 (AUTHOR), Yu, Dongrong1 (AUTHOR), Yin, Jiazhen1 (AUTHOR), Yu, Jin1 (AUTHOR)
Publikováno v:
Analytical Cellular Pathology: Cellular Oncology. 9/30/2022, p1-8. 8p.